Skip to main content
. 2016 Dec 27;8(10):16650–16668. doi: 10.18632/oncotarget.14287

Figure 7. Significant pathways enriched in high-risk patients.

Figure 7

(A) Significant pathways enriched in high-risk patients using GSEA of differentially regulated genes in high-risk and low-risk patients. (B, C, D, E) GSEA representation of selected significant enriched pathways in high risk group, namely TNFa signalling via NFκB (B), inflammatory response (C), Epithelial mesenchymal transition (D) and hypoxia (E).